BioXcel Therapeutics, Inc. (BTAIQ): Form 8-K filed 2026-09-01
- Accepted by EDGAR
- 2026-09-01 07:01 ET
- Event date
- 2026-08-31
- Accession no.
- 0001104659-26-104106
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The company became obligated under a material direct financial obligation, such as a loan, notes offering or credit facility draw, or under a material off-balance sheet arrangement. - Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | tm2624539d1_8k.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.